Immutep Webinar to Discuss Final Overall Survival Data Presentation from the AIPAC Study of Eftilagimod in Metastatic Breast Cancer at SITC 2021
About The Event
The webinar will feature a presentation by Immutep’s management team:
- Frederic Triebel MD, PhD (Chief Scientific and Chief Medical Officer of Immutep)
- Christian Mueller (Vice President, Strategic Development of Immutep)
- Marc Voigt (Executive Director and Chief Executive Officer of Immutep)
Immutep’s management team will discuss the final overall survival data from the AIPAC study investigating eftilagimod in metastatic breast cancer patients presented at SITC 2021.
An analyst question and answer session will follow the formal presentations.